1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Prostate Cancer Nuclear Medicine Diagnostics Market – By Type

1.3.2        SAM Prostate Cancer Nuclear Medicine Diagnostics Market – By PET Product

1.3.3        SAM Prostate Cancer Nuclear Medicine Diagnostics Market – By End User

1.3.4        SAM Prostate Cancer Nuclear Medicine Diagnostics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Prostate Cancer Nuclear Medicine Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        SAM PEST Analysis

4.3         Experts Opinion

5.           SAM Prostate Cancer Nuclear Medicine Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Prostate Cancer

5.1.2        Surging Demand for Early and Precise Diagnosis of Prostate Cancer

5.2         Market Restraints

5.2.1        High Cost Related to the Prostate Cancer Diagnostics and Treatment

5.3         Market Opportunities

5.3.1        Growing Use of Radiopharmaceuticals in Prostate Cancer

5.4         Future Trends

5.4.1        Increasing Research Activities for Development of Innovative Imaging Agents

5.5         Impact Analysis

6.           Prostate Cancer Nuclear Medicine Diagnostics Market– SAM Analysis

6.1         SAM Prostate Cancer Nuclear Medicine Diagnostics Market Revenue Forecast and Analysis

7.           SAM Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By Type

7.1         Overview

7.2         Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2022 & 2028 (%)

7.3         SPECT

7.3.1        Overview

7.3.2        SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4         PET

7.4.1        Overview

7.4.2        PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8.           SAM Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By PET Product

8.1         Overview

8.2         SAM Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2022 & 2028 (%)

8.3         F-18

8.3.1        Overview

8.3.2        F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         C-11

8.4.1        Overview

8.4.2        C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5         GA 68 PSMA

8.5.1        Overview

8.5.2        GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           SAM Prostate Cancer Nuclear Medicine Diagnostics Market – By End User

9.1         Overview

9.2         SAM Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User- 2022 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        SAM Prostate Cancer Nuclear Medicine Diagnostics Market – By Country Analysis

10.1      SAM Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028

10.1.1     Overview

10.1.2     SAM: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)

10.1.2.1       Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       Overview

10.1.2.1.2       Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3       Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (USD Million)

10.1.2.1.4       Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2019–2028 (USD Million)

10.1.2.1.5       Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.2.2       Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       Overview

10.1.2.2.2       Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3       Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (USD Million)

10.1.2.2.4       Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2019–2028 (USD Million)

10.1.2.2.5       Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.2.3       Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       Overview

10.1.2.3.2       Rest of SAM: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3       Rest of SAM: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (USD Million)

10.1.2.3.4       Rest of SAM: Prostate Cancer Nuclear Medicine Diagnostics Market , by PET Product, 2019–2028 (USD Million)

10.1.2.3.5       Rest of SAM: Prostate Cancer Nuclear Medicine Diagnostics Market , by End User, 2019–2028 (USD Million)

11.        Company Profiles

11.1      ImaginAb

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Curium

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      ABX advanced biochemical compounds GmbH

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Telix Pharmaceuticals Ltd.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Novartis AG

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Lantheus Medical Imaging, Inc.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product – Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 4.             Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 5.             Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product – Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7.             Rest of SAM: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product – Revenue and Forecast to 2028 (USD Million)

Table 9.             Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 10.          Glossary of Terms, Prostate Cancer Nuclear Medicine Diagnostics Market

LIST OF FIGURES

Figure 1.           SAM Prostate Cancer Nuclear Medicine Diagnostics Market Segmentation

Figure 2.           SAM Prostate Cancer Nuclear Medicine Diagnostics Market, By Country

Figure 3.           SAM Prostate Cancer Nuclear Medicine Diagnostics Market Overview

Figure 4.           PET Segment Held Largest Share of Type Segment in Prostate Cancer Nuclear Medicine Diagnostics Market

Figure 5.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           SAM: PEST Analysis

Figure 7.           SAM Experts Opinion

Figure 8.           SAM Prostate Cancer Nuclear Medicine Diagnostics Market Impact Analysis of Drivers and Restraints

Figure 9.           SAM Prostate Cancer Nuclear Medicine Diagnostics Market– Revenue Forecast and Analysis – 2022 - 2028

Figure 10.        Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2022 & 2028 (%)

Figure 11.        SAM SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        SAM PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        SAM Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2022 & 2028 (%)

Figure 14.        SAM F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15.        SAM C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16.        SAM GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        SAM Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User - 2022 & 2028 (%)

Figure 18.        SAM Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        SAM Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        SAM Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        SAM: Prostate Cancer Nuclear Medicine Diagnostics Market, by Key Country – Revenue (2022) (USD Million)

Figure 22.        SAM: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)

Figure 23.        Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.        Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        Rest of SAM: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)